We are live on ! Find out more
ACM

Aster Capital Management Portfolio holdings

AUM $306M
1-Year Est. Return 18%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$441M
AUM Growth
-$98.8M
Cap. Flow
-$107M
Cap. Flow %
-24.13%
Top 10 Hldgs %
14.81%
Holding
1,671
New
470
Increased
188
Reduced
316
Closed
697

Top Buys

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$12M
2
XOM icon
ExxonMobil
XOM
+$6.52M
3
IYR icon
iShares US Real Estate ETF
IYR
+$5.82M
4
PG icon
Procter & Gamble
PG
+$5.61M
5
PGR icon
Progressive
PGR
+$5.53M

Sector Composition

Rank Sector Weight
1 Financials 17.2%
2 Technology 12.73%
3 Industrials 12.41%
4 Consumer Discretionary 11.3%
5 Healthcare 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMDX icon
776
Transmedics
TMDX
$2.79B
$11.3K ﹤0.01%
84
-10,629
-99% -$1.17M
UTZ icon
777
Utz Brands
UTZ
$1.25B
$11.1K ﹤0.01%
888
-509
-36% -$6.66K
BFAM icon
778
Bright Horizons
BFAM
$3.98B
$10.9K ﹤0.01%
88
-1,882
-96% -$231K
SHOO icon
779
Steven Madden
SHOO
$3.58B
$10.9K ﹤0.01%
+453
New +$10.6K
NATL icon
780
NCR Atleos
NATL
$3.47B
$10.8K ﹤0.01%
380
-75
-16% -$2.02K
EXEL icon
781
Exelixis
EXEL
$14.1B
$10.8K ﹤0.01%
+245
New +$9.79K
PBH icon
782
Prestige Consumer Healthcare
PBH
$2.46B
$10.8K ﹤0.01%
135
-385
-74% -$32.2K
UFPT icon
783
UFP Technologies
UFPT
$2.59B
$10.7K ﹤0.01%
+44
New +$9.9K
NPO icon
784
Enpro
NPO
$7.07B
$10.7K ﹤0.01%
56
-272
-83% -$46.5K
APLS
785
DELISTED
Apellis Pharmaceuticals
APLS
$10.7K ﹤0.01%
+617
New +$11.4K
GYRE icon
786
Gyre Therapeutics
GYRE
$686M
$10.6K ﹤0.01%
1,447
+1,388
+2,353% +$12.1K
INDI icon
787
indie Semiconductor
INDI
$769M
$10.6K ﹤0.01%
2,980
-30,180
-91% -$76K
HIMS icon
788
Hims & Hers Health
HIMS
$7.44B
$10.4K ﹤0.01%
+209
New +$9.45K
IAUX
789
i-80 Gold Corp
IAUX
$1.21B
$10.4K ﹤0.01%
+17,353
New +$10.2K
MMSI icon
790
Merit Medical Systems
MMSI
$5.12B
$10.3K ﹤0.01%
+110
New +$10.4K
PL icon
791
Planet Labs
PL
$8.14B
$10.1K ﹤0.01%
+1,660
New +$6.78K
STEX
792
Streamex Corp
STEX
$81.2M
$10.1K ﹤0.01%
+1,415
New +$4.96K
CUBI icon
793
Customers Bancorp
CUBI
$2.83B
$9.99K ﹤0.01%
+170
New +$8.61K
CRC icon
794
California Resources
CRC
$4.66B
$9.77K ﹤0.01%
+214
New +$8.75K
ABCB icon
795
Ameris Bancorp
ABCB
$6B
$9.77K ﹤0.01%
151
-122
-45% -$7.23K
GRC icon
796
Gorman-Rupp
GRC
$2.26B
$9.73K ﹤0.01%
+265
New +$9.53K
JKHY icon
797
Jack Henry & Associates
JKHY
$11.1B
$9.73K ﹤0.01%
+54
New +$9.59K
LQDT icon
798
Liquidity Services
LQDT
$1.19B
$9.72K ﹤0.01%
+412
New +$11.1K
WABC icon
799
Westamerica Bancorp
WABC
$1.39B
$9.69K ﹤0.01%
200
-20,026
-99% -$960K
DVN icon
800
Devon Energy
DVN
$50.8B
$9.67K ﹤0.01%
+304
New +$9.68K

Similar funds

Aster Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Aster Capital Management held 1,671 positions worth $441M, down 18% from $540M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aster Capital Management withdrew a net $107M in Q2 2025, closing 697 positions and reducing 316 holdings. Its most notable exit was Invesco S&P 500 Equal Weight ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Aster Capital Management opened a new position in Palantir worth $13.9M.

  • Aster Capital Management's largest Q2 2025 buy was Palantir: 102,034 shares worth $13.9M.
  • Aster Capital Management added most to ExxonMobil in Q2 2025, an estimated $6.52M increase.
  • Aster Capital Management's biggest Q2 2025 reduction was State Street SPDR S&P Retail ETF, cutting an estimated $5.88M.
  • Aster Capital Management fully exited Invesco S&P 500 Equal Weight ETF in Q2 2025, selling an estimated $13.7M.
  • Aster Capital Management's ten largest holdings make up 15% of its $441M portfolio in Q2 2025.
  • Aster Capital Management opened 470 new positions and closed 697 in Q2 2025.
  • Aster Capital Management's portfolio value fell 18% quarter-over-quarter to $441M.

Based on Aster Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.